EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
165
Frequently Asked Questions
What is Market Cap of EyePoint Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. EyePoint Pharmaceuticals Inc market cap is $958.09M.
What is the 52-week high for EyePoint Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. EyePoint Pharmaceuticals Inc 52 week high is $14.42 as of September 27, 2025.
What is the 52-week low for EyePoint Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. EyePoint Pharmaceuticals Inc 52 week low is $3.91 as of September 27, 2025.
What is EyePoint Pharmaceuticals Inc stock price today?
EyePoint Pharmaceuticals Inc stock price today is $13.90.
What was EyePoint Pharmaceuticals Inc stock price yesterday?
EyePoint Pharmaceuticals Inc stock price yesterday was $13.19.
What is the PE ratio of EyePoint Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. EyePoint Pharmaceuticals Inc’s P/E ratio is -5.19.
What is the Price-to-Book ratio of EyePoint Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. EyePoint Pharmaceuticals Inc P/B ratio is 3.8924.
What is the 50-day moving average of EyePoint Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. EyePoint Pharmaceuticals Inc 50-day moving average is $11.75.
How many employess does EyePoint Pharmaceuticals Inc has?